6CF-29255-63155 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-01-24
Dose 1 — Pfizer-BioNTech
2022-01-25
Registered in v-safe
2022-01-25
Survey response — days 1–6 daily, dose 1, dependent
MedDRA: Chest pain — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Chest pains

MedDRA releases: 2024-11 · check-in free text available
2022-01-26
Survey response — days 1–6 daily, dose 1, dependent
MedDRA: Chest pain — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Chest pains

MedDRA releases: 2024-11 · check-in free text available
2022-01-27
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2022-01-28
Health check-in — days 1–6 daily, dose 1, dependent
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-01-24	Pfizer-BioNTech	No

Free text

Release 11 — days 1–6 daily, dose 1, dependent

2022-01-25

Systemic reaction (other): Chest pains

2022-01-26

Systemic reaction (other): Chest pains

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Chest pain	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release